🇺🇸 FDA
Patent

US 9999673

PEGylated lipids and their use for drug delivery

granted A61KA61K31/713A61K47/18

Quick answer

US patent 9999673 (PEGylated lipids and their use for drug delivery) held by Alnylam Pharmaceuticals, Inc. expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/713, A61K47/18, A61K47/6911, A61K9/1272